D
Integra LifeSciences Holdings Corporation IART
$13.01 $0.090.70% NASDAQ
Recommendation
Prev Close
$13.51
Volume
770,942
Avg Vol (90D)
846,607
Market Cap
$1.05B
Dividend & Yield
--
52-Week Range
$11.60 - $32.66
P/E (TTM)
--
EPS (TTM)
-$0.3782
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud ...
5/15/2025 - GuruFocus
IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm
5/15/2025 - Business Wire
Commit To Buy Integra LifeSciences Holdings At $10, Earn 10% Annualized Using Options
5/15/2025 - Stock Options Channel
Integra LifeSciences Holdings Co. (NASDAQ:IART) Position Cut by D. E. Shaw & Co. Inc.
5/15/2025 - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
5/13/2025 - Globe Newswire
Algert Global LLC Grows Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)
5/13/2025 - MarketBeat
Integra LifeSciences Holdings (IART, $13.67) RSI Indicator left the oversold zone on May 12, 2025
5/13/2025 - Tickeron - Stocks
Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 28% Dip In Price Shows Sentiment Is Matching Revenues
5/11/2025 - Simply Wall St
92,105 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Acquired by Expect Equity LLC
5/11/2025 - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Acquired by Algert Global LLC
5/11/2025 - Ticker Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
5/9/2025 - Globe Newswire
JPMorgan Chase & Co. Lowers Integra LifeSciences (NASDAQ:IART) Price Target to $12.00
5/8/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Price Target Lowered to $13.00 at Wells Fargo & Company
5/8/2025 - MarketBeat
Clearline Capital LP Sells 187,583 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)
5/8/2025 - Ticker Report
Raymond James Financial Inc. Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART)
5/8/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Hits New 1-Year Low After Earnings Miss
5/8/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Shares Gap Down After Earnings Miss
5/7/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Releases Earnings Results, Misses Expectations By $0.02 EPS
5/7/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Updates FY 2025 Earnings Guidance
5/7/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Updates Q2 2025 Earnings Guidance
5/7/2025 - MarketBeat
Integra LifeSciences Holdings (IART, $12.75) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 6, 2025
5/7/2025 - Tickeron - Technical Analysis
Q1 Earnings Highlights: Teleflex (NYSE:TFX) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
5/7/2025 - StockStory Articles
Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
5/7/2025 - StockStory Articles
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
5/6/2025 - PR Newswire
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut
5/6/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$1.62B
EBITDA (TTM)
$315.61M
EBIT (TTM)
$168.10M
Net Income (TTM)
-$28.96M
Balance Sheet
Total Assets (Q)
$4.05B
Total Debt (Q)
$2.02B
Total Liabilities (Q)
$2.53B
Book Value Per Share (Q)
$19.61
Cash Flow
Cash from Operations (TTM)
$102.37M
Cash from Investing (TTM)
-$372.76M
Cash from Financing (TTM)
-$85.44M
Net Change in Cash (TTM)
-$352.80M
Filings
Filing Date
Monday, May 5, 2025
Period Date
Monday, March 31, 2025
Next Filing
End of July (est)
Price History
Loading...
Beta
1.12
7-Day Total Return
-2.03%
30-Day Total Return
-39.80%
60-Day Total Return
-44.21%
90-Day Total Return
-43.48%
Year to Date Total Return
-43.48%
1-Year Total Return
-50.79%
2-Year Total Return
-73.66%
3-Year Total Return
-78.21%
5-Year Total Return
-72.49%
52-week Low
May 05, 2025 - $11.60
52-week High
Jul 17, 2024 - $32.66
Valuation
Market Cap
$1.05B - Small Cap
Enterprise Value
$2.80B
Price/Sales (TTM)
0.64
Price/Book (Q)
0.69
Dividends and Shares
Shares Outstanding
76.46M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.integralife.com
Phone Number
609 275 0500
Address
1100 Campus Road
Princeton, NJ 08540
Country
United States
Year Founded
1989
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and... more
NASDAQ 05/15/2025 4:00PM Eastern Quotes delayed